Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.240
0.00 (0.00%)
At close: Aug 5, 2026, 4:00 PM EDT
2.290
+0.050 (2.23%)
After-hours: Aug 5, 2026, 7:43 PM EDT
Acumen Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Acumen Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $7.40. The average 1-year stock price forecast is 230.36% higher than the current stock price, while the lowest is $4.00 (+78.57%) and the highest is $10 (+346.43%).
Price Target: $7.40 (+230.36%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 11, 2026.
Analyst Ratings
The average analyst rating for Acumen Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $8 | Buy | Maintains | $8 | +257.14% | Jun 11, 2026 |
| BTIG | BTIG | Buy Maintains $8 | Buy | Maintains | $8 | +257.14% | Apr 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.58
from -2.00
EPS Next Year
-1.51
from -1.58
EPS and Forward PE are based on non-GAAP adjusted numbers.